There are 410 resources available
10MO - EMPOWER-Lung 1: Cemiplimab (CEMI) monotherapy as first-line (1L) treatment of patients (pts) with brain metastases from advanced non-small cell lung cancer (aNSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50% — 3-year update
Presenter: Saadettin Kilickap
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast
No
Presenter: Alessandra Curioni-Fontecedro
Session: Adjuvant chemotherapy in EGFR mutated NSCLC
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Laura Mezquita
Session: Adjuvant chemotherapy in EGFR mutated NSCLC
Resources:
Slides
Webcast
11MO - Final data from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3) and pembrolizumab in 2nd-line metastatic NSCLC pts resistant to PD-1/PD-L1 inhibitors
Presenter: Margarita Majem Tarruella
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast
12MO - Patterns of response in metastatic (m) NSCLC after 2 and 4 cycles of chemotherapy (CT), alone or with durvalumab (D) ± tremelimumab (T), in the phase III POSEIDON study
Presenter: Niels Reinmuth
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast
Invited Discussant 114MO, 10MO, 11MO and 12MO
Presenter: Nir Peled
Session: Mini Oral 2
Resources:
Slides
Webcast
13MO - Safety and efficacy of tusamitamab ravtansine in combination with pembrolizumab ± chemotherapy in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05 phase II study)
Presenter: Luis Paz-Ares
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast
14MO - Updated efficacy and safety of taletrectinib in patients (pts) with ROS1+ non-small cell lung cancer (NSCLC)
Presenter: Wei Li
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast
15MO - Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with larotrectinib
Presenter: Martin Hoejgaard
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast
16MO - Clinical impact of plasma EGFR analysis: Results from the ETOP-BOOSTER randomized phase II trial
Presenter: Ross Soo
Session: Mini Oral 2
Resources:
Abstract
Slides
Webcast